Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
Author:
Affiliation:
1. Department of Comprehensive Surgery General Hospital of Chinese People's Liberation Army & National Clinical Research Center for Geriatric Disease Beijing China
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23643
Reference33 articles.
1. Hyperuricemia is associated with sympathovagal imbalance in older adults;Passos RS;Arch Gerontol Geriatr,2020
2. Physical function, Hyperuricemia, and gout in older adults;Burke BT;Arthritis Care Res (Hoboken),2015
3. Febuxostat compared with allopurinol in patients with hyperuricemia and gout;Becker MA;N Engl J Med,2005
4. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28‐week, phase III, randomized, double‐blind, parallel‐group trial;Schumacher HR;Arthritis Rheum,2008
5. FAST: new look at the febuxostat safety profile;Bardin T;Lancet,2020
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia;JCR: Journal of Clinical Rheumatology;2023-12-20
2. Agents for the Treatment of Gout: Current Advances and Future Perspectives;Journal of Medicinal Chemistry;2023-11-01
3. Biodegradation of Inosine and Guanosine by Bacillus paranthracis YD01;International Journal of Molecular Sciences;2023-09-23
4. Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Cardiovascular Development and Disease;2023-09-04
5. Cardiovascular safety of xanthine oxidase inhibitors: an optimistic and unfinished story;Modern Rheumatology Journal;2023-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3